Bio Techne | TECH - 税前利润



金融业
股票价格
USD
资产
USD 2.55B
现金及等价物
USD 264.71M
销售成本
USD 103.13M
流动资产
USD 688.05M
流动负债
USD 153.28M
债务
USD 200M
股息收益率
0.61
EBIT
USD 75.5M
EBITDA
USD 115.94M
员工
3.1K
EPS每股收益
USD 0.52
股本和储备
USD 2.09B
销售毛利
USD 222.15M
债务利息支出
USD 3.6M
利息收入
USD 981K
贷款资金
USD 200M
市值
USD 11.37B
净收入
USD 51.05M
营业费用
USD 235.92M
营业利润
USD 75.5M
普通股股本
USD 156.45M
PE价格收益
38.75
税前利润
USD 106.09M
销售收入
USD 321.2M
销售和管理费用
USD 109.34M
股票
USD 195.74M
贸易债权人
USD 95.6M
应收帐款人
USD 214.56M


税前利润 更改 日
Agilent USD 364M 78M 2025-12
Becton, Dickinson and Co. USD 39M 354M 2026-03
Bio Techne USD 106.09M 34.87M 2026-06
Bio-Rad Laboratories USD 542.1M 1.23B 2026-06
Bruker USD 117M 95.1M 2026-06
Charles River Laboratories USD -29.94M 264.16M 2026-03
Danaher USD 1.08B 157M 2026-06
Illumina USD 260M 103M 2026-06
IQVIA Holdings USD 301M 5.92B 2026-06
Merck EUR 869M 468M 2026-03
Mettler Toledo International USD 209.66M 119.42M 2026-03
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Repligen USD 14.15M 12.38M 2026-06
Revvity USD 187.24M 137.25M 2026-06
Standard Biotools USD -14.62M 7.42M 2026-03
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Waters USD 356M 444M 2026-06